Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Apr;93(4):955–963. doi: 10.1111/j.1476-5381.1988.tb11485.x

Modification by steroids of pulmonary oedema and prostaglandin E2 pharmacokinetics induced by endotoxin in rats.

T Izumi 1, Y S Bakhle 1
PMCID: PMC1853897  PMID: 3292000

Abstract

1. A single i.p. injection of bacterial endotoxin in rats (3.5 mg kg-1) caused lung injury assessed as changes in lung dry:wet weight ratio and leukopaenia over the subsequent 28 h. 2. This treatment also slowed the efflux of 14C from [14C]-prostaglandin E2 (PGE2), i.e., increased t1/2 and increased the survival of PGE2 in isolated perfused lungs over the same period. 3. These effects of endotoxin were reversed by methylprednisolone (30 mg kg-1), given 30 min after the endotoxin. 4. Another synthetic corticosteroid, budesonide (1.2 mg kg-1) given 1 h before endotoxin partially prevented the lung injury and leukopaenia but did not affect the increased t1/2 for PGE2 nor its survival. 5. The reversal by methylprednisolone of both the physical signs of lung injury and the changes in PGE2 pharmacokinetics caused by endotoxin suggests that changes in PGE2 pharmacokinetics could serve as an index of acute lung injury following sepsis.

Full text

PDF
955

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Kaisi N., Parratt J. R., Siddiqui H. H., Zeitlin I. J. Feline endotoxin shock: effects of methylprednisolone on kininogen-depletion, on the pulmonary circulation and on survival. Br J Pharmacol. 1977 Jul;60(3):471–476. doi: 10.1111/j.1476-5381.1977.tb07524.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson F. L., Tsagaris T. J., Jubiz W., Kuida H. Prostaglandin F and E levels during endotoxin-induced pulmonary hypertension in calves. Am J Physiol. 1975 May;228(5):1479–1482. doi: 10.1152/ajplegacy.1975.228.5.1479. [DOI] [PubMed] [Google Scholar]
  3. Bakhle Y. S. Decreased inactivation of prostaglandin E2 in isolated lungs from rats with alpha-naphthyl thiourea-induced pulmonary oedema. Biochem Pharmacol. 1982 Nov 1;31(21):3395–3401. doi: 10.1016/0006-2952(82)90617-7. [DOI] [PubMed] [Google Scholar]
  4. Bakhle Y. S., Grantham C. J. Effects of pulmonary oedema on pharmacokinetics of adenosine in rat isolated lungs. Br J Pharmacol. 1987 Aug;91(4):849–856. doi: 10.1111/j.1476-5381.1987.tb11284.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bakhle Y. S., Grantham C. J. Selective effect of pulmonary oedema on prostaglandin E2 pharmacokinetics in rat lung. Biochem Pharmacol. 1985 Dec 15;34(24):4325–4327. doi: 10.1016/0006-2952(85)90292-8. [DOI] [PubMed] [Google Scholar]
  6. Bakhle Y. S., Pankhania J. J. Inhibitors of prostaglandin dehydrogenase (Ph CL 28A and Ph CK 61A) increase output of prostaglandins from rat isolated lung. Br J Pharmacol. 1987 Sep;92(1):189–196. doi: 10.1111/j.1476-5381.1987.tb11311.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bakhle Y. S., Reynard A. M., Vane J. R. Metabolism of the angiotensins in isolated perfused tissues. Nature. 1969 Jun 7;222(5197):956–959. doi: 10.1038/222956a0. [DOI] [PubMed] [Google Scholar]
  8. Blackwell G. J., Flower R. J., Vane J. R. Rapid reduction of prostaglandin 15-hydroxy dehydrogenase activity in rat tissues after treatment with protein synthesis inhibitors. Br J Pharmacol. 1975 Oct;55(2):233–238. doi: 10.1111/j.1476-5381.1975.tb07633.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Blaisdell F. W. Controversy in shock research. Con: The role of steroids in septic shock. Circ Shock. 1981;8(6):673–682. [PubMed] [Google Scholar]
  10. Borg T., Alvfors A., Gerdin B., Modig J. A porcine model of early adult respiratory distress syndrome induced by endotoxaemia. Acta Anaesthesiol Scand. 1985 Nov;29(8):814–830. doi: 10.1111/j.1399-6576.1985.tb02306.x. [DOI] [PubMed] [Google Scholar]
  11. Borg T., Gerdin B., Modig J. Prophylactic and delayed treatment with high-dose methylprednisolone in a porcine model of early ARDS induced by endotoxaemia. Acta Anaesthesiol Scand. 1985 Nov;29(8):831–845. doi: 10.1111/j.1399-6576.1985.tb02307.x. [DOI] [PubMed] [Google Scholar]
  12. Brigham K. L., Bowers R. E., McKeen C. R. Methylprednisolone prevention of increased lung vascular permeability following endotoxemia in sheep. J Clin Invest. 1981 Apr;67(4):1103–1110. doi: 10.1172/JCI110123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Brigham K. L., Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis. 1986 May;133(5):913–927. [PubMed] [Google Scholar]
  14. Chaudhari A., Sivarajah K., Warnock R., Eling T. E., Anderson M. W. Inhibition of pulmonary prostaglandin metabolism by exposure of animals to oxygen or nitrogen dioxide. Biochem J. 1979 Oct 15;184(1):51–57. doi: 10.1042/bj1840051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Coker S. J., Hughes B., Parratt J. R., Rodger I. W., Zeitlin I. J. The release of prostanoids during the acute pulmonary response to E. coli endotoxin in anaesthetized cats. Br J Pharmacol. 1983 Mar;78(3):561–570. doi: 10.1111/j.1476-5381.1983.tb08816.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ekström B. F., Kuenzig M., Schwartz S. I. Pulmonary platelet trapping in Escherichia coli endotoxin-injected dogs treated with methylprednisolone, ibuprofen and naloxone. Acta Chir Scand. 1986 Mar;152:181–185. [PubMed] [Google Scholar]
  17. Fletcher J. R., Ramwell P. W. Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog. Br J Pharmacol. 1977 Oct;61(2):175–181. doi: 10.1111/j.1476-5381.1977.tb08402.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Freeman B. A., Crapo J. D. Biology of disease: free radicals and tissue injury. Lab Invest. 1982 Nov;47(5):412–426. [PubMed] [Google Scholar]
  19. Glauser F. L., Fairman R. P. The uncertain role of the neutrophil in increased permeability pulmonary edema. Chest. 1985 Oct;88(4):601–607. doi: 10.1378/chest.88.4.601. [DOI] [PubMed] [Google Scholar]
  20. Hinshaw L. B., Archer L. T., Beller-Todd B. K., Coalson J. J., Flournoy D. J., Passey R., Benjamin B., White G. L. Survival of primates in LD100 septic shock following steroid/antibiotic therapy. J Surg Res. 1980 Feb;28(2):151–170. doi: 10.1016/0022-4804(80)90158-4. [DOI] [PubMed] [Google Scholar]
  21. Hinson J. M., Jr, Hutchison A. A., Ogletree M. L., Brigham K. L., Snapper J. R. Effect of granulocyte depletion on altered lung mechanics after endotoxemia in sheep. J Appl Physiol Respir Environ Exerc Physiol. 1983 Jul;55(1 Pt 1):92–99. doi: 10.1152/jappl.1983.55.1.92. [DOI] [PubMed] [Google Scholar]
  22. Klein L. S., Fisher A. B., Soltoff S., Coburn R. F. Effect of O2 exposure on pulmonary metabolism of prostaglandin E2. Am Rev Respir Dis. 1978 Sep;118(3):622–625. doi: 10.1164/arrd.1978.118.3.622. [DOI] [PubMed] [Google Scholar]
  23. Källström L., Brattsand R., Lövgren U., Svensjö E., Roempke K. A rat model for testing anti-inflammatory action in lung and the effect of glucocorticosteroids (GCS) in this model. Agents Actions. 1986 Jan;17(3-4):355–357. doi: 10.1007/BF01982644. [DOI] [PubMed] [Google Scholar]
  24. Meyrick B. O., Ryan U. S., Brigham K. L. Direct effects of E coli endotoxin on structure and permeability of pulmonary endothelial monolayers and the endothelial layer of intimal explants. Am J Pathol. 1986 Jan;122(1):140–151. [PMC free article] [PubMed] [Google Scholar]
  25. Minty B. D., Scudder C. M., Grantham C. J., Jones J. G., Bakhle Y. S. Sequential changes in lung metabolism, permeability, and edema after ANTU. J Appl Physiol (1985) 1987 Feb;62(2):491–496. doi: 10.1152/jappl.1987.62.2.491. [DOI] [PubMed] [Google Scholar]
  26. Modig J. Adult respiratory distress syndrome. Pathogenesis and treatment. Acta Chir Scand. 1986 Apr;152:241–249. [PubMed] [Google Scholar]
  27. Nakano J., Prancan A. V. Metabolic degradation of prostaglandin E1 in the lung and kidney of rats in endotoxin shock. Proc Soc Exp Biol Med. 1973 Nov;144(2):506–508. doi: 10.3181/00379727-144-37623. [DOI] [PubMed] [Google Scholar]
  28. Oettinger W. K., Walter G. O., Jensen U. M., Beyer A., Peskar A. Endogenous prostaglandin F2 alpha in the hyperdynamic state of severe sepsis in man. Br J Surg. 1983 Apr;70(4):237–239. doi: 10.1002/bjs.1800700417. [DOI] [PubMed] [Google Scholar]
  29. Parkes D. G., Eling T. E. The influence of environmental agents on prostaglandin biosynthesis and metabolism in the lung. Inhibition of lung 15-hydroxyprostaglandin dehydrogenase by exposure of guinea pigs to 100 per cent oxygen at atmospheric pressure. Biochem J. 1975 Mar;146(3):549–556. doi: 10.1042/bj1460549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rinaldo J. E., Rogers R. M. Adult respiratory-distress syndrome: changing concepts of lung injury and repair. N Engl J Med. 1982 Apr 15;306(15):900–909. doi: 10.1056/NEJM198204153061504. [DOI] [PubMed] [Google Scholar]
  31. Schraufstätter I. U., Revak S. D., Cochrane C. G. Proteases and oxidants in experimental pulmonary inflammatory injury. J Clin Invest. 1984 Apr;73(4):1175–1184. doi: 10.1172/JCI111303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schumer W. Controversy in shock research. Pro: The role of steroids in septic shock. Circ Shock. 1981;8(6):667–671. [PubMed] [Google Scholar]
  33. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg. 1976 Sep;184(3):333–341. doi: 10.1097/00000658-197609000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Sibbald W. J., Anderson R. R., Reid B., Holliday R. L., Driedger A. A. Alveolo-capillary permeability in human septic ARDS. Effect of high-dose corticosteroid therapy. Chest. 1981 Feb;79(2):133–142. doi: 10.1378/chest.79.2.133. [DOI] [PubMed] [Google Scholar]
  35. Sprung C. L., Caralis P. V., Marcial E. H., Pierce M., Gelbard M. A., Long W. M., Duncan R. C., Tendler M. D., Karpf M. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med. 1984 Nov 1;311(18):1137–1143. doi: 10.1056/NEJM198411013111801. [DOI] [PubMed] [Google Scholar]
  36. Tate R. M., Repine J. E. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis. 1983 Sep;128(3):552–559. doi: 10.1164/arrd.1983.128.3.552. [DOI] [PubMed] [Google Scholar]
  37. Toivonen H., Hartiala J., Bakhle Y. S. Effects of high oxygen tension on the metabolism of vasoactive hormones in isolated perfused rat lungs. Acta Physiol Scand. 1981 Feb;111(2):185–192. doi: 10.1111/j.1748-1716.1981.tb06723.x. [DOI] [PubMed] [Google Scholar]
  38. Watts I. S., Zakrzewski J. T., Bakhle Y. S. Altered prostaglandin synthesis in isolated lungs of rats with streptozotocin-induced diabetes. Thromb Res. 1982 Nov 1;28(3):333–342. doi: 10.1016/0049-3848(82)90115-3. [DOI] [PubMed] [Google Scholar]
  39. Weigelt J. A., Norcross J. F., Borman K. R., Snyder W. H., 3rd Early steroid therapy for respiratory failure. Arch Surg. 1985 May;120(5):536–540. doi: 10.1001/archsurg.1985.01390290018003. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES